NL8301722A - Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. - Google Patents
Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. Download PDFInfo
- Publication number
- NL8301722A NL8301722A NL8301722A NL8301722A NL8301722A NL 8301722 A NL8301722 A NL 8301722A NL 8301722 A NL8301722 A NL 8301722A NL 8301722 A NL8301722 A NL 8301722A NL 8301722 A NL8301722 A NL 8301722A
- Authority
- NL
- Netherlands
- Prior art keywords
- weight
- cimetidine
- sodium salicylate
- indomethacin
- ulcer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU153582 | 1982-05-14 | ||
HU153582 | 1982-05-14 | ||
HU153682 | 1982-05-14 | ||
HU153682A HU188167B (en) | 1982-05-14 | 1982-05-14 | Process for producing new pharmaceutical compositions against ulcer |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8301722A true NL8301722A (nl) | 1983-12-01 |
Family
ID=26317386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8301722A NL8301722A (nl) | 1982-05-14 | 1983-05-13 | Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. |
Country Status (13)
Country | Link |
---|---|
AR (1) | AR230570A1 (xx) |
AU (1) | AU1459183A (xx) |
BE (1) | BE896711A (xx) |
CA (1) | CA1211374A (xx) |
CH (1) | CH655243A5 (xx) |
DD (1) | DD209735A5 (xx) |
DE (1) | DE3317578A1 (xx) |
DK (1) | DK215883D0 (xx) |
FI (1) | FI831687L (xx) |
FR (1) | FR2527078B1 (xx) |
GB (1) | GB2120938B (xx) |
NL (1) | NL8301722A (xx) |
SE (1) | SE8302689L (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189788B1 (de) * | 1985-01-23 | 1989-09-13 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika |
US5260333A (en) * | 1986-08-08 | 1993-11-09 | Bristol Myers Squibb Company | Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
GB8625325D0 (en) * | 1986-10-22 | 1986-11-26 | Glaxo Group Ltd | Chemical compounds |
GB8629781D0 (en) * | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
WO1992015332A1 (en) * | 1991-03-04 | 1992-09-17 | Warner-Lambert Company | Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
ES2130152T3 (es) * | 1991-12-06 | 1999-07-01 | Glaxo Group Ltd | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. |
HU213101B (en) * | 1992-12-29 | 1997-02-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU170329B (xx) * | 1974-12-12 | 1977-05-28 | ||
US4198402A (en) * | 1975-12-17 | 1980-04-15 | Richter Gedeon Vegyeszeti Gyar Rt. | Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment |
US4200631A (en) * | 1975-12-17 | 1980-04-29 | Richter Gedeon Vegyeszeti Gyar Rt. | Treating mammalian subject sensitive to indomethacin ulcerogenisis |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
-
1983
- 1983-05-10 BE BE0/210740A patent/BE896711A/fr not_active IP Right Cessation
- 1983-05-10 CA CA000427820A patent/CA1211374A/en not_active Expired
- 1983-05-10 SE SE8302689A patent/SE8302689L/xx not_active Application Discontinuation
- 1983-05-13 DD DD25091383A patent/DD209735A5/de not_active IP Right Cessation
- 1983-05-13 DE DE19833317578 patent/DE3317578A1/de not_active Withdrawn
- 1983-05-13 FI FI831687A patent/FI831687L/fi not_active Application Discontinuation
- 1983-05-13 DK DK215883A patent/DK215883D0/da not_active Application Discontinuation
- 1983-05-13 GB GB08313269A patent/GB2120938B/en not_active Expired
- 1983-05-13 CH CH262683A patent/CH655243A5/de not_active IP Right Cessation
- 1983-05-13 FR FR8307985A patent/FR2527078B1/fr not_active Expired
- 1983-05-13 NL NL8301722A patent/NL8301722A/nl not_active Application Discontinuation
- 1983-05-13 AU AU14591/83A patent/AU1459183A/en not_active Abandoned
- 1983-05-13 AR AR29301383A patent/AR230570A1/es active
Also Published As
Publication number | Publication date |
---|---|
FR2527078A1 (fr) | 1983-11-25 |
CH655243A5 (de) | 1986-04-15 |
SE8302689D0 (sv) | 1983-05-10 |
DK215883D0 (da) | 1983-05-13 |
DE3317578A1 (de) | 1983-12-01 |
FI831687L (fi) | 1983-11-15 |
FI831687A0 (fi) | 1983-05-13 |
GB2120938B (en) | 1985-09-18 |
FR2527078B1 (fr) | 1987-06-12 |
BE896711A (fr) | 1983-09-01 |
GB2120938A (en) | 1983-12-14 |
DD209735A5 (de) | 1984-05-23 |
GB8313269D0 (en) | 1983-06-22 |
AR230570A1 (es) | 1984-05-31 |
SE8302689L (sv) | 1983-11-15 |
AU1459183A (en) | 1983-11-17 |
CA1211374A (en) | 1986-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1035854A1 (en) | Use of alpha-glucosidase inhibitors for treating high-risk impaired glucose tolerance | |
KR20010013618A (ko) | 치료학적 활성 조성물 | |
KR101516677B1 (ko) | 지방성 간 질환의 치료용 의약 조성물 | |
HUT71476A (en) | Pharmaceutical compositions for inhibition of ldl oxidation and atherosclerosis containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation | |
HUT71327A (en) | Pharmaceutical compositions for inhibition of autoimmune diseases containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation | |
NL8301722A (nl) | Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. | |
KR100625399B1 (ko) | 리파아제 억제제 및 글루코마난을 포함하는 약학 조성물 | |
KR100515918B1 (ko) | 면역 조절용 약학 조성물 | |
Petersen et al. | Medication-induced oesophageal disorders | |
WO1997045141A1 (fr) | Remede pour maladies auto-immunes | |
EP1030664A1 (en) | Pharmaceutical compositions containing zafirlukast | |
HU200684B (en) | Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and active on gastrointestinal tract | |
KR0175345B1 (ko) | 장점막 장애 예방 및 치료제 | |
EP0679394B1 (en) | Menatetronome derivative as antiarteriosclerotic agent | |
JP4203170B2 (ja) | 医薬組成物 | |
KR100817932B1 (ko) | 베르바민을 유효성분으로 포함하는 혈관 재협착 예방제 | |
JP4931598B2 (ja) | 腸ポリープ抑制剤 | |
US3080286A (en) | Constipation correctives | |
JP4426654B2 (ja) | 免疫調節用医薬組成物 | |
AU2003243986A1 (en) | A pharmaceutical composition for preventative and/or therapeutic treatment of constipation and symptom resulting in constipation | |
JP2004168766A (ja) | α−グルコシダーゼ阻害剤 | |
JP2898930B2 (ja) | 消化器症状改善剤 | |
JP2006327996A (ja) | 血糖の上昇を抑制するための薬剤または機能性食品 | |
IL44996A (en) | Pharmaceuticals Containing History 5 - Mercaptopyridoxine for the Treatment of Rheumatoid Arthritis | |
HU206616B (en) | Process for producing pharmaceutical compositions containing pharmaceutically active tetrahydro-naphtalene derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |